Interní Med. 2010; 12(6): 302-305

Non-steroidal antiphlogistics in gastroenterology

doc.MUDr.Zdena Zádorová, Ph.D.
II. interní klinika FNKV, III. LF UK, Praha

The large majority of peptic ulcerations that are not associated with H. pylori infection are associated with NSAID ingestion. Peptic ulceration

with NSAIDs typically causes no symptoms, but NSAID – induced ulcers can be symptomatic and complicated by GI bleeding,

perforation and/or obstruction. Asymptomatic ulcerations can be documented endoscopically in 15 % to 45 % of patients on chronic

NSAID therapy.

Keywords: NSAID, gastrointestinal ulcers, gastrointestinal bleeding

Published: July 1, 2010  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zádorová Z. Non-steroidal antiphlogistics in gastroenterology. Interní Med. 2010;12(6):302-305.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Rybár I, Hyrdel R, Rovenský J. Peptické léze navozené léčbou nesteroidními antiflogistiky. In Jurgoš L, Kužela L, Hrušovský, et al. Gastroenterologia. VEDA Bratislava; 2006: 289-297.
    2. Allison MC, Howatson AG, Torrance CJ, et al. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med 1992; 327: 749. Go to original source... Go to PubMed...
    3. Laine L. Approaches to non-steroidal anti-inflammatory drug use in the high-risk patients. Gastroenterology 2001; 120: 594. Go to original source... Go to PubMed...
    4. Langman MJS, Weil J, Wainwright P, et al. Risk of bleeding peptic ulcer associated with individual nonsteroidal anti-inflammatory drugs. Lancet 1994; 343: 1075-1078. Go to original source... Go to PubMed...
    5. Soll AH, Weinstein WM, Kurata J, et al. Nonsteroidal anti-inflammatory drugs and peptic ulcer disease. Ann Intern Med 1995; 123: 241.
    6. Bjarnason I, Hayllar J, Macherson AJ, et al. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans. Gastroenterology 1993; 104: 1832. Go to original source... Go to PubMed...
    7. Nagar AB, Proctor DD. Ulcers of the small and large intestine. In Sleisenger and Fordtran´s. Gastrointestinal and Liver disease. Saunders Elsevier, 8th edition; 2006: 2587-2612.
    8. Rockey DC. Gastrointestinal bleeding. In Sleisenger and Fordtran´s. Gastrointestinal and Liver disease. Saunders Elsevier, 8th edition, 2006: 255-299.
    9. Pavelka K. Nesteroidní antiflogistika (antirevmatika) pro celkovou terapii. In Remedia. Compendium III. vydání, 1999: 523-533.
    10. Cryer B, Spechler SJ. Peptic ulcer disease. In Sleisenger and Fordtran´s. Gastrointestinal and Liver disease. Saunders Elsevier, 8th edition, 2006: 1089-1137.
    11. Dítě P, Seifert B, Lukáš K, et al. Prevence a léčba gastropatie z nesteroidních antirevmatik (antiflogistik). Čes a slov Gastroent a Hepatol, 2004; 58(4): 148-150.
    12. Wallace JL, McKnight W, Reuter B, et al. NSAID induced gastric damage in rats. Requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology 2000; 119: 706. Go to original source... Go to PubMed...
    13. Aalykke C, Lauritsen JM, Hallas J, et al. Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs. A case-control study. Gastroenterology 1999; 116: 1305. Go to original source... Go to PubMed...
    14. Chan FK, To KF, Wu JC, et al. Eradication of Helicobacter pylori and risk of peptic ulcer in patients starting longterm treatment with non-steroidal anti-inflammatory drugs: a randomised trial. Lancet 2002; 359: 9-13. Go to original source... Go to PubMed...
    15. Rokkas T, Karameris A, Mavrogeorgis A, et al. Eradication of Helicobacter pylori reduces the possibility of rebleeding in peptic ulcer disease. Gastrointest Endosc 1995; 41: 1. Go to original source... Go to PubMed...
    16. Bjarnason I, Hayllar J, Smethurst P, et al. Metronidazole reduces intestinal inflammation and blood loss in nonsteroidal anti-inflammatory drug induced enteropathy. GUT 1990; 33: 1204. Go to original source... Go to PubMed...
    17. Goldstein JI, Eisen G, Lewis B, et al. Celecoxib is associated with fewer small bowel lesions than naproxen + omeprazol in healthy subjects as determinated by capsule endoscopy. Am J Gastroenterol 2003; 98(Suppl): S297. Go to original source... Go to PubMed...
    18. Tibble JA, Sigthhorsson G, Foster R, et al. High prevalence of NSAID enteropathy as shown by a simple faecal test. GUT 1999; 45: 362. Go to original source... Go to PubMed...

    Return to the content


    Internal Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.